TCOT
LCTX icon

Trust Company of Toledo’s Lineage Cell Therapeutics LCTX Stock Holding History

Trust Company of Toledo’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Hold
83,795
– – 0.01% 366
2026
Q1 		$132K Buy
83,795
+50,000
+148% +$84.3K 0.01% 325
2025
Q4 		$56.4K Hold
33,795
– – 0.01% 415
2025
Q3 		$57.1K Hold
33,795
– – 0.01% 415
2025
Q2 		$30.7K Hold
33,795
– – ﹤0.01% 475
2025
Q1 		$15.3K Hold
33,795
– – ﹤0.01% 237
2024
Q4 		$17K Hold
33,795
– – ﹤0.01% 236
2024
Q3 		$30.6K Hold
33,795
– – ﹤0.01% 234
2024
Q2 		$33.7K Hold
33,795
– – ﹤0.01% 230
2024
Q1 		$50K Hold
33,795
– – 0.01% 224
2023
Q4 		$36.8K Hold
33,795
– – 0.01% 216
2023
Q3 		$39.9K Sell
33,795
-1,599
-5% -$2.17K 0.01% 208
2023
Q2 		$49.9K Buy
35,394
+10,394
+42% +$14.4K 0.01% 200
2023
Q1 		$37.5K Buy
+25,000
New +$34.9K 0.01% 201

Other funds holding LCTX

DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RCWM
Red Crane Wealth Management San Francisco, California $136M AUM 18.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Trust Company of Toledo's LCTX Position: Q2 2026 in Review

Trust Company of Toledo held its Lineage Cell Therapeutics (LCTX) position steady in Q2 2026 at 83,795 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #366.

Trust Company of Toledo first reported a position in LCTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $132K in Q1 2026. 33 funds tracked by Wall St. Rank hold LCTX as of Q2 2026.

  • Trust Company of Toledo held 83,795 shares of Lineage Cell Therapeutics worth $110K as of Q2 2026.
  • Trust Company of Toledo left its Lineage Cell Therapeutics share count unchanged in Q2 2026.
  • Lineage Cell Therapeutics made up 0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #366 holding.
  • Trust Company of Toledo first reported a position in Lineage Cell Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Trust Company of Toledo's Lineage Cell Therapeutics position peaked at $132K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.